Factors Associated with the Expression of ACE2 in Human Lung Tissue: Pathological Evidence from Patients with Normal FEV1 and FEV1/FVC
Wuping Bao,Xue Zhang,Yubiao Jin,Huijuan Hao,Fu Yang,Dongning Yin,Xi Chen,Yishu Xue,Lei Han,Min Zhang
DOI: https://doi.org/10.2147/jir.s300747
IF: 4.5
2021-04-29
Journal of Inflammation Research
Abstract:Wuping Bao, 1, * Xue Zhang, 1, * Yubiao Jin, 2, * Huijuan Hao, 1 Fu Yang, 3 Dongning Yin, 1 Xi Chen, 3 Yishu Xue, 1 Lei Han, 1 Min Zhang 1 1 Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 3 Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China *These authors contributed equally to this work Correspondence: Min Zhang Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100, Haining Road, Shanghai, 200080, People's Republic of China Email Background: Whether COVID-19 comorbidities and risk factors such as old age, male gender, smoking, obesity, eosinophils and blood types have direct contact with expression of ACE2 and pro-inflammation cytokines in human lung tissues were still unclear. Patients and Methods: Sixty-four patients with normal FEV 1 and FEV 1 /FVC underwent thoracotomy for pulmonary nodules were included. Blinded histological assessments were performed by two pathologists. Clinical features and results of the immunohistochemical staining of ACE2 were collected and analyzed. Results: ACE2 expressed in alveolar macrophages (most obvious), alveolar epithelia and vascular endothelia, but not in small-airway epithelia. ACE2 expressions are positively related to age ( r =0.26, P =0.040), weight ( r =0.43, P < 0.001), as well as BMI ( r = 0.38, P =0.002), and male patients show higher expressions of ACE2 in lungs ( P < 0.05). ACE2 expressions are negatively related to peripheral eosinophils ( r = − 0.30, P =0.017). There was no correlation between ABO blood types and ACE2 expression in normal lung tissues ( P > 0.05). IL-13 and IL-6R expression in lung tissue increased with age ( r =0.26, P < 0.05, for both). Conclusion: Our pathological evidences showed that the alveolar epithelia, vascular endothelia, and alveolar macrophages are susceptible in human lungs for SARS-CoV-2 infection. The risk factors such as high body weight/BMI, old age, male gender, and eosinopenia may be related to ACE2 expression in human lungs, and associated with more chance to develop the severe cases. IL-6R expression in lung tissue also increased with age. Therefore, weight control and smoking cessation are essential to reduce the susceptibility of SARS-CoV-2 infection, especially in obesity, old or male patients. Peripheral eosinophils monitor is also quite necessary to detect severe tendency in COVID-19 patients. Keywords: ACE2, risk factor, BMI, age, sex, eosinophils A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leading to the coronavirus disease 2019 (COVID-19) was first identified in December 2019 and rapidly swept across the globe. More than 85 million people have been confirmed and more than 1.8 million people dead worldwide (as of December 2020). 1 It has been estimated that 1 in 5–10 adults with positive COVID-19 requiring hospital admission, 2 with rates of admission to the intensive care unit (ICU) in China, Europe, and the United States ranging from 5% to 32%. 3–11 The severity of COVID-19 illness poses a great strain to medical resources and a great burden to social economy. Therefore, early identification of risk factors of COVID-19 is essential to protect susceptible population, and might help to provide proper prevention, close observation and treatment. Many potential COVID-19 comorbidities and risk factors such as coronary artery disease, hypertension, diabetes, COPD, asthma, autoimmune disease, old age, male gender, smoking, and obesity have been demonstrated to affect the process and severity of COVID-19 illness. 12 , 13 And the effect of some risk factors, such as eosinophils and blood types in COVID-19 is still controversial. SARS-CoV-2 attaches and enters host cells first via a transmembrane receptor angiotensin-converting enzyme 2 (ACE2). ACE2 is widely distributed in various human tissues, and in the respiratory system, it is mainly expressed in -Abstract Truncated-
immunology